The doc, seen by Reuters and ready by the European Fee, exhibits that the EU expects to get 413 million doses within the second quarter of this yr, and one other 529 million within the July-September interval, after receiving 106 million within the first quarter.
Over 1 billion doses estimated by the tip of September could be adequate to immunise your complete EU inhabitants of 450 million, effectively past the EU’s preliminary purpose of vaccinating no less than 70% of its grownup inhabitants by the tip of the summer season.
The estimates have in mind solely vaccines from 4 drugmakers: Pfizer-BionTech, Johnson & Johnson, AstraZeneca and Moderna.
They exclude doses from German biotech agency CureVac and French drugmaker Sanofi, which have signed contracts with the EU for lots of of tens of millions of doses however are struggling to develop their vaccines and get them permitted by EU regulators.
Pfizer and BioNTech account for over half of provides within the second quarter of this yr and for almost 40% of whole deliveries within the third quarter, the doc stated.
The EU expects to obtain one other 452 million doses within the fourth quarter of the yr, together with a number of million from AstraZeneca, though it had been required to ship all its 300 million contracted doses by the tip of June.